roniciclib

Ligand id: 7874

Name: roniciclib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 8
Topological polar surface area 116.57
Molecular weight 430.13
XLogP 4.07
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
IUPAC Name
(2R,3R)-3-((2-((4-(cyclopropanesulfonimidoyl)phenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)oxy)butan-2-ol
International Nonproprietary Names
INN number INN
9806 roniciclib
Synonyms
BAY 10-00394 | BAY 1000394 | KB-145902
Database Links
CAS Registry No. 1223498-69-8
PubChem CID 45380979
Search Google for chemical match using the InChIKey UELYDGOOJPRWGF-MFOHZAOFSA-N
Search Google for chemicals with the same backbone UELYDGOOJPRWGF
Search PubMed clinical trials roniciclib
Search PubMed titles roniciclib
Search PubMed titles/abstracts roniciclib
Search UniChem for chemical match using the InChIKey UELYDGOOJPRWGF-MFOHZAOFSA-N
Search UniChem for chemicals with the same backbone UELYDGOOJPRWGF
SynPHARM 80716 (in complex with cyclin dependent kinase 2)
Comments
Roniciclib is an orally bioavailable cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity, with selectively for CDK1/cyclin B, CDK2/cyclin E, CDK4/cyclin D1, and CDK9/cyclin T1, which play key roles in the regulation of cell cycle progression and cellular proliferation [1-2].